MGC Pharma
APRIL 4, 2018
A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals. Thursday March 29 was a day of celebration on MGC Pharma’s timeline as we announced the commencement of production for the first batch of CannEpil™. CannEpil™?—?CBD-based treatment for people with Refractory Epilepsy?—?is the first product we’ve released to market.
MMJ Recs
APRIL 4, 2018
With over half of U.S. states legalizing medical marijuana (29 at last count), the drug is starting to be accepted as something more than simply an outlier treatment; it is a genuine, progressive form of therapy with tangible results. Although MMJ faced (and still faces, in some states) stiff opposition from conservative politicians, the wave of advocacy has been equally strong, leading to a steady increase in legalization over the years.
Expert insights. Personalized for you.
100 
Let's personalize your content